Zotefoams PLC Notice of Results (4414S)

TIDMZTF

RNS Number : 4414S

Zotefoams PLC

09 July 2020

9 July 2020

Zotefoams plc

("Zotefoams')

Notice of Results

Zotefoams, a world leader in cellular materials technology, will announce its interim results for the six months to 30 June 2020 on 11 August 2020.

An analyst meeting will take place at 9.30am on the day. Analysts interested in attending the presentation should please contact IFC Advisory: [e-mail]

In addition, David Stirling, Group CEO, and Gary McGrath, Group CFO, will be hosting an interactive presentation on Investor Meet Company at 5.30pm on 11 August 2020:

https://investormeetcompany.com/zotefoams-plc/register-investor

 
      --   The online presentation is open to all existing and potential 
            shareholders. 
      --   Questions can be submitted pre-event via your IMC dashboard 
            or any time during the live presentation via the "Ask 
            a Question" function. Although Zotefoams may not be in 
            a position to answer every question it receives, it will 
            address the most prominent within the confines of information 
            already disclosed to the market. Responses to the Q&A 
            from the live presentation will be published at the earliest 
            opportunity on the Investor Meet Company platform. 
      --   Investor feedback can also be submitted directly to management 
            post-event to ensure Zotefoams can understand the views 
            of all elements of its shareholder base. 
 

Enquiries:

Zotefoams plc 44 (0) 208 664 1600

David Stirling, Group CEO

Gary McGrath, Group CFO

   IFC Advisory (Financial PR & IR)                                        44 (0) 203 934 6630 

Graham Herring

Zach Cohen

About Zotefoams plc

Zotefoams plc (LSE - ZTF) is a world leader in cellular materials technology delivering optimal material solutions for the benefit of society. Utilising a variety of unique manufacturing processes, including environmentally friendly nitrogen expansion for lightweight AZOTE(R) polyolefin and ZOTEK(R) high-performance foams, Zotefoams sells to diverse markets worldwide. Zotefoams uses its own cellular materials to manufacture T-FIT(R) advanced insulation for demanding industrial markets. Zotefoams also owns and licenses patented microcellular foam technology to reduce plastic use in extrusion applications and for ReZorce(R) mono-material recyclable barrier packaging.

Zotefoams is headquartered in Croydon, UK, with additional manufacturing sites in Kentucky and Oklahoma, USA (foam products manufacture and conversion), Massachusetts, USA (MuCell Extrusion) and Jiangsu Province, China (T-FIT(R)). A third foam-manufacturing site, in Poland, is planned to begin operations in 2020.

www.zotefoams.com

AZOTE(R), ZOTEK(R), ReZorce(R) and T-FIT(R) are registered trademarks of Zotefoams plc.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

NORRPMITMTTMBFM

(END) Dow Jones Newswires

July 09, 2020 02:00 ET (06:00 GMT)